Weil am Rhein
Germany
24
2016-04-14
The entities that hold a legal rights for patent applications filed by inventor Hoffmann Torsten:
Torsten Hoffmann from Weil am Rhein, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
#2 | 2014-05-15Small molecule conjugates for intracellular delivery of biologically active compounds
#3 | 2014-05-15Small molecule conjugates for intracellular delivery of nucleic acids
#4 | 2013-10-24Peptide-based in vivo siRNA delivery system
#5 | 2013-09-19Compositions for targeted delivery of siRNA
#6 | 2013-07-25In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#7 | 2012-07-05In vivo polynucleotide delivery conjugates having enzyme sensitive linkages
#8 | 2012-06-28Peptide-based in vivo siRNA delivery system
#9 | 2012-06-21Galactose cluster-pharmacokinetic modulator targeting moiety for siRNA
#10 | 2012-04-19-pyridin-3-yl or -pyrazin-2-yl carboxamides
#11 | 2011-08-25Compositions for targeted delivery of siRNA
#12 | 2011-07-21Dual NK1/NK3 receptor antagonists
#13 | 2011-03-03METHOD OF TREATMENT AND/OR PREVENTION OF BRAIN, SPINAL OR NERVE INJURY
#14 | 2010-06-24Compounds
#15 | 2009-05-28Dual NK1/NK3 receptor antagonists
#16 | 2008-11-06Pyrrolidine derivatives as dual NK1/NK3 receptor antagonists
#17 | 2007-06-07Serotonin transporter (SERT) inhibitors for the treatment of depression and anxiety
#18 | 2007-01-09Crystalline modifications of 2-(3,5-bis-trifluoromethyl-phenyl)-N-[6-(1,1-dioxo-1 λ-thiomorpholin-4-yl)-4-(4-fluoro-2-methyl-phenyl)-pyridin-3-yl]-N-methyl-isobutyramide
#19 | 2006-11-02Method of treatment and/or prevention of brain, spinal or nerve injury
#20 | 2006-09-28NK-1 receptor antagonists
#21 | 2006-08-24Bi-pyridinyl derivatives as NK-1 antagonists
#22 | 2005-05-24NK-1 receptor active amine oxide prodrugs
#23 | 2005-04-28Dual NK1/NK3 receptor antagonists
#24 | 2005-02-01Aromatic and heteroaromatic substituted amides
355986 ⎘